Evidence map›Paper›PMID 22261438›Full record

ArticleImmunity2012

The transcription factors T-bet and Eomes control key checkpoints of natural killer cell maturation.

Scott M Gordon, Julie Chaix, Levi J Rupp, Junmin Wu, Sharline Madera, Joseph C Sun, Tullia Lindsten, Steven L Reiner

Open access · bronzeAbstract read
In one paragraph

Article in Immunity, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 452 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
452citing papers in PubMed, 3 pooled it
21.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

452 citing papers in PubMed, 3 syntheses or guidelines pooled it, 711 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. T-bet Fate Mapping Reveals Gestational Stage-Specific Transcriptional Adaptation of Decidual NK Cells.American journal of reproductive immunology (New York, N.Y. : 1989) · 2026
    Article
  18. Article
  19. Article
  20. Review

392 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Scott M GordonAbramson Family Cancer Research Institute, Philadelphia, PA 19104, USA.
Julie Chaix
Levi J Rupp
Junmin Wu
Sharline Madera
Joseph C Sun
Tullia Lindsten
Steven L Reiner
Cancer Research Institute · USMemorial Sloan Kettering Cancer Center · USUniversity of Pennsylvania · US

Funding

Weill Cornell/Rockefeller/Sloan-Kettering MST ProgramT32GM007739 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI HSU, KATHARINE C · 1985 to 2023
$51.1M
IMMUNOBIOLOGY OF NORMAL AND NEOPLASTIC LYMPHOCYTEST32CA009140 · NCI · UNIVERSITY OF PENNSYLVANIA · PI Malay Haldar, WARREN S PEAR · 1985 to 2026
$16.1M
The natural killer cell response against mouse cytomegalovirus infectionR01AI100874 · NIAID · SLOAN-KETTERING INST CAN RESEARCH · PI Joseph Chai-Yuen Sun · 2012 to 2026
$7.4M
HELPER T CELL REGULATION IN MURINE LEISHMANIASISR01AI042370 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI REINER, STEVEN L · 1998 to 2012
$4.8M
Control of CD8+ Effector T Cell DifferentiationR01AI061699 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI REINER, STEVEN L · 2005 to 2015
$4.0M
Asymmetric Lymphocyte Division in the Immune ResponseR01AI076458 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI REINER, STEVEN L · 2008 to 2019
$3.7M
Self-renewing Lymphocyte Division in The Immune ResponseR56AI076458 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI REINER, STEVEN L · 2014 to 2021
$802k
NCI NIH HHS T32 CA009140NCI NIH HHS T32 CA09140NIAID NIH HHS AI042370NIAID NIH HHS AI061699NIAID NIH HHS AI076458NIAID NIH HHS R01 AI042370NIAID NIH HHS R01 AI061699NIAID NIH HHS R01 AI076458NIAID NIH HHS R01 AI100874NIAID NIH HHS R56 AI076458NIGMS NIH HHS T32 GM007739
6 · The paper itself

Abstract

Natural killer (NK) cells play critical roles defending against tumors and pathogens. We show that mice lacking both transcription factors Eomesodermin (Eomes) and T-bet failed to develop NK cells. Developmental stability of immature NK cells constitutively expressing the death ligand TRAIL depended on T-bet. Conversely, maturation characterized by loss of constitutive TRAIL expression and induction of Ly49 receptor diversity and integrin CD49b (DX5(+)) required Eomes. Mature NK cells from which Eomes was deleted reverted to phenotypic immaturity if T-bet was present or downregulated NK lineage antigens if T-bet was absent, despite retaining expression of Ly49 receptors. Fetal and adult hepatic hematopoiesis restricted Eomes expression and limited NK development to the T-bet-dependent, immature stage, whereas medullary hematopoiesis permitted Eomes-dependent NK maturation in adult mice. These findings reveal two sequential, genetically separable checkpoints of NK cell maturation, the progression of which is metered largely by the anatomic localization of hematopoiesis.

Indexed as

Cell DifferentiationAnimalsCell CycleCell LineageFlow CytometryGene DeletionKiller Cells, NaturalMiceMice, KnockoutModels, ImmunologicalReal-Time Polymerase Chain ReactionT-bet Transcription FactorT-Box Domain ProteinsEomes protein, mouseT-bet Transcription FactorT-Box Domain Proteins

Identifiers

PMID22261438
PMCPMC3381976
OpenAlexW1993565885

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.